Oxygen-saving effect of a new cardiotonic agent, MCI-154, in diseased human hearts

Journal of the American College of Cardiology

Volumn 29, Issue 3, 1997, Pages 613-622

  Mori, Masuki ^a   Takeuchi, Motoshi ^a   Takaoka, Hideyuki ^a   Hata, Katsuya ^a   Hayashi, Yoshihiko ^a   Yamakawa, Hideyuki ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4,5 DIHYDRO 6 [4 (4 PYRIDYLAMINO)PHENYL] 3(2H) PYRIDAZINONE; CARDIOTONIC AGENT; DOBUTAMINE;

ARTICLE; HEART CATHETERIZATION; HEART DISEASE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

AGED; CARDIOTONIC AGENTS; CONSTRICTION, PATHOLOGIC; CORONARY DISEASE; DOBUTAMINE; ENERGY METABOLISM; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXYGEN CONSUMPTION; PYRIDAZINES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 0031059160     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00534-7     Document Type: Article

References (40)

1. ++ as an inotropic mechanism. Circulation 1986;73 Suppl III:85-98.
2. Ferrier GR, Saunders JH, Mendez C. A cellular mechanism for the generation of ventricular arrhythmias by acetylstrophanthidin. Circ Res 1973;32:600-9.
3. Capogrossi MC, Houser SR, Bahinski A, Lakatta EG. Synchronous occurrence of spontaneous localized calcium release from the sarcoplasmic reticulum generates action potentials in rat cardiac ventricular myocyte at normal resting membrane potential. Circ Res 1987;61:498-503.
4. Lee JA, Allen DG. Altering the strength of the heart: basic mechanisms. In: Lee JA, Allen DG, editors. Modulation of Cardiac Calcium Sensitivity: A New Approach to Increasing the Strength of the Heart. Oxford (UK): Oxford University Press, 1993:1-36.
5. Parmley WW. Pathophysiology and current therapy of congestive heart failure. J Am Coll Cardiol 1989;13:771-85.
6. 2+ in intact and skinned trabeculae from control and myopathie human hearts. J Clin Invest 1988;82: 1578-84.
7. 2+ transient in rat myocardium. J Mol Cell Cardiol 1991;23:325-31.
8. 2+ in isolated ferret cardiac muscle. Circ Res 1993;73:61-70.
9. Cottney J, Logan R, Marshall R, Nicholson D, Shahid M, Walker G. Org 30029: a new cardiotonic agent possessing both phosphodiesterase inhibitory and calcium-sensitizing properties. Cardiovasc Drugs Rev 1990;8:179-202.
10. Narimatsu A, Kitada Y, Satoh N, Suzuki R, Okushima H. Cardiovascular pharmacology of 6-[4-(4′-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-piridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties. Arzneimittlforsch/Drug Res 1987;37:398-406.
11. Allert JA, Adams HR. Inotropic and chronotropic profile of MCI-154: comparison with isoproterenol and imazodan in guinea pig cardiac prepa-rations. J Cardiovasc Pharmacol 1990;16:59-67.
12. Kitada Y, Narimatsu A, Suzuki R, Endo M, Taira N. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP. J Pharmacol Exp Ther 1987;243:639-45.
13. 2+ sensitivity of reconstituted thin filament: a study using a novel in vitro motility assay technique. Circ Res 1995;76:626-33.
14. ++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig. J Pharmacol Exp Ther 1987;243:633-8.
15. 2+ activation of skinned human myocardium. Eur J Pharmacol 1989;165: 305-8.
16. ++ binding by MCI-154, a novel cardiotonic agent. J Pharmacol Exp Ther 1989;250:272-7.
17. Odake M, Takeuchi M, Takaoka H, Hata K, Hayashi Y, Yokoyama M. Determination of left ventricular volume using a conductance catheter in the diseased human heart. Eur Heart J 1992;13 Suppl E:22-7.
18. Takaoka H, Takeuchi M, Odake M, et al. Comparison of hemodynamic determinants for myocardial oxygen consumption under different contractile states in human ventricle. Circulation 1993;87:59-69.
19. Takaoka H, Takeuchi M, Odake M, et al. Comparison of the effects on arterial-ventricular coupling between phosphodiesterase inhibitor and do-butamine in the diseased human heart. J Am Coll Cardiol 1993;22:598-606.
20. Mori M, Takeuchi M, Takaoka H, Hata K, Hayashi Y, Yokoyama M. Effect of NKH 477, a new water-soluble forskolin derivative, on arterial-ventricular coupling and mechanical energy transduction in patients with left ventricular systolic dysfunction: comparison with dobutamine. J Cardiovasc Pharmacol 1994;24:310-6.
21. Takeuchi M, Igarashi Y, Tomimoto S, et al. Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation 1991;83:202-12.
22. 2+ sensitization with a new cardiotonic agent, MCI-154, on diseased human hearts. Cardiovasc Res 1995;30:915-22.
23. Baan J, Van der Velde ET, DeBruin HG, et al. Continuous measurement of left ventricular volume in animals and human by conductance catheter. Circulation 1984;70:812-23.
24. Burkhoff D, Van der Velde ET, Kass D, Baan J, Maughan WL, Sagawa K. Accuracy of volume measurement by conductance catheter in isolated, ejecting canine hearts. Circulation 1985;72:440-47.
25. Sagawa K, Maughan WL, Suga H, Sunagawa K. Cardiac Contraction and the Pressure-Volume Relationship. Oxford (UK): Oxford University Press, 1988.
26. Suga H. Ventricular energetics. Physiol Rev 1990;70:247-77.
27. Sunagawa K, Maughan WL, Sagawa K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 1985;56:586-95.
28. McKay RG, Aroesty JM, Heller GV, Royal HD, Warren SE, Grossman W. Assessment of the end-systolic pressure-volume relationship in human beings with the use of a time-varying elastance model. Circulation 1986;74: 97-104.
29. Suga H, Hisano R, Goto Y, Yamada O, Igarashi Y. Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure volume area in canine left ventricle. Circ Res 1983;53:306-18.
30. Goto Y, Slinker BK, LeWinter MM. Effects of amrinone and isoproterenol on mechanoenergetics of blood-perfused rabbit heart. Am J Physiol 1992; 262:H719-27.
31. Hata K, Goto Y, Futaki S, et al. Mechanoenergetic effects of pimobendan in canine left ventricles comparison with dobutamine. Circulation 1992;86: 1291-301.
32. Ohgoshi Y, Goto Y, Futaki S, Yaku H, Kawaguchi O, Suga H. Increased oxygen cost of contractility in stunned myocardium of dog. Circ Res 1991;69:975-88.
33. + exchange system. Circ Res 1994;74:794-805.
34. De Tombe PP, Burkhoff D, Hunter WC. Effects of calcium and EMD-53998 on oxygen consumption in isolated canine hearts. Circulation 1992;86:1945-54.
35. Endoh M, Shibasaki T, Satoh H, Norota I, Ishihata A. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 CL in canine ventricular myocardium. J Cardiovasc Pharmacol 1991;17:365-75.
36. Solaro JR, Gambassi G, Warshaw DM, et al. Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilament. Circ Res 1993;73:981-90.
37. 2+ transients and tension in rat ventricular muscle. Pflugers Arch 1987;409:427-37.
38. Hayashi Y, Takeuchi M, Takaoka H, Hata K, Mori M, Yokoyama M. Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction: increased oxygen cost of contractility. Circulation 1996;93:932-9.
39. Gwathmey JK, Copelas L, MacKinnon R, et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987;61:70-6.
40. Burkhoff D, Sugiura S, Yue DT, Sagawa K. Contractility-dependent curvilinearity of end-systolic pressure-volume relations. Am J Physiol 1987;252: H1218-27.